KX52 (Auryxia 210 mg (ferric iron))
Generic Name: ferric citrate
Pill imprint KX52 has been identified as Auryxia 210 mg (ferric iron).
Auryxia is used in the treatment of hyperphosphatemia of renal failure and belongs to the drug class phosphate binders. There is no proven risk in humans during pregnancy. Auryxia 210 mg (ferric iron) is not a controlled substance under the Controlled Substance Act (CSA).
More about Auryxia (ferric citrate)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.